Pertussis

aka whooping cough
Etiology Bordetella pertussis, despite sounding like a cheese, is a gram negative coccobacillus.
Epidemiology Incomplete immunisation = ↑↑ risk
Pathogenesis Virulence factors:
- fimbriae
- exotoxin → thickened bronchial secretions, paralysis of cilia
Clinical presentation - Incubation 7-10 days
- 1-2 weeks nonspecific symptoms → classic cough +/- vomiting after coughing fits
➥ infants more likely to show atypical s/s: apnoea, difficulty feeding
➥ Cough can last 2-3 months (100-day cough)
Higher risk if incomplete immunisation
Investigations Nasopharyngeal swab
If symptoms present >2/52, pertussis IgG serology can be used if age >17
FBC: lymphocytosis
Management Symptomatic management -
Macrolides - only really effective if established before paroxysms
Antibiotics do not alter the clinical course once the disease is established
- Considered noninfectious after 3/52 hence no abx after 3/52 symptoms - or 14 days according to CKS...
HIGHLY infectious, R0 = 15-17
Complications: apnoeas, cyanosis

Prescribing

  • Prescribe a macrolide first line: 
    • For infants aged under 1 month, clarithromycin is preferred. Azithromycin may be used although there are limited data in this age group.
    • For children aged over 1 year, prescribe azithromycin or clarithromycin.
    • For non-pregnant adults, prescribe azithromycin or clarithromycin.
    • For pregnant women, prescribe erythromycin. The second line option is azithromycin and third line clarithromycin, as alternatives where necessary. 
  • If macrolides are contraindicated or not tolerated, prescribe co-trimoxazole.
    • Do not prescribe co-trimoxazole to pregnant women or infants younger than six weeks old.

role of abx

  • microbiological eradication
  • no difference in mortality
  • Applies to:
    • Children
    • staff working with children including school and healthcare workers
  • stay out from school until:
    • 48h on appropriate abx
    • 21 days from onset of coughing if no abx and well enough to return
  • avoid contact with infants under one year who are unvaccinated, partially vaccinated, or pregnant women

Post-exposure

Vaccination
Catch up on any missed vax
Booster if last dose >5y ago
Prophylaxis:

  • is for:
    • those at ↑ risk complications, or
    • ↑ risk transmission
  • macrolide 1st line = clarithromycin/azithromycin; erythromycin in pregnant patients; co-trimoxazole if macrolides contraindicated

Vaccine uptake 92.9% of 2yos in 2023 vs 96.3% in 2014

vaccination

Time frame Vaccine
2 months DTaP/IPV/Hib
3 months DTaP/IPV/Hib
4 months DTaP/IPV/Hib
Preschool DTaP/IPV
  • also offered in pregnancy → ↓ risk of infant death from pertussis by 92%!

external links